Canopy Growth (CGC) Non-Current Deferred Tax Liability (2017 - 2026)
Canopy Growth (CGC) reported Non-Current Deferred Tax Liability of $6.0 million for Q1 2026, up 569.26% sequentially from $893343.0 in Q2 2023.
Canopy Growth (CGC) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 8 years of Non-Current Deferred Tax Liability data on file, last reported at $6.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $6.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (changed N/A YoY), and the FY2026 full-year result was $6.0 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability climbed to $6.0 million in Q1 2026, from $893343.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $12.6 million in Q1 2022 to a low of $264071.6 in Q1 2023.
- A 3-year average of $6.5 million and a median of $6.6 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability slipped 25.26% in 2022 and tumbled 97.91% in 2023, its largest moves.
- Tracing CGC's Non-Current Deferred Tax Liability over 3 years: stood at $6.6 million in 2022, then plunged by 86.51% to $893343.0 in 2023, then surged by 569.26% to $6.0 million in 2026.
- Business Quant data shows CGC's Non-Current Deferred Tax Liability at $6.0 million in Q1 2026, $893343.0 in Q2 2023, and $264071.6 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98 Mn |
| Mar 31, 2026 | 5.98 Mn |
| Jun 30, 2023 | 893,342.96 |
| Jun 30, 2023 | 893,342.96 |
| Mar 31, 2023 | 264,071.60 |
| Mar 31, 2023 | 264,071.60 |
| Dec 31, 2022 | 6.62 Mn |
| Dec 31, 2022 | 6.62 Mn |
| Sep 30, 2022 | 7.48 Mn |
| Sep 30, 2022 | 7.48 Mn |
| Jun 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 11.50 Mn |
| Mar 31, 2022 | 12.62 Mn |
| Mar 31, 2022 | 12.62 Mn |
| Dec 31, 2021 | 21.71 Mn |
| Dec 31, 2021 | 21.71 Mn |
| Sep 30, 2021 | 20.23 Mn |
| Sep 30, 2021 | 20.23 Mn |
| Jun 30, 2021 | 21.62 Mn |
| Jun 30, 2021 | 21.62 Mn |